Abstract
Metabolomics, alone or in combination with other omics sciences, has shown great relevance in a large number of investigations in different branches of biomedicine, often providing novel discoveries and helping to expand the knowledge. Metabolomics analyses are carried out using different techniques, but in this chapter, we focus on liquid chromatography coupled to high-resolution mass spectrometry. The designated methodology consists of an untargeted approach for the analysis of plasma samples. The use of this method, with a reverse-phase column and electrospray ionization in positive mode, covers the detection of a broad range of metabolites, mainly of nonpolar and of intermediate polarity. This chapter also reviews the mass fragmentation spectra for the identification of bile acids, acylcarnitines, and glycerophospholipids.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Martín-Blázquez A, Díaz C, González-Flores E et al (2019) Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer. Sci Rep 9(1):1–9. https://doi.org/10.1038/s41598-019-55952-8
García-Fontana B, Morales-Santana S, Díaz Navarro C et al (2016) Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: a pilot study. Talanta 148:135–143. https://doi.org/10.1016/j.talanta.2015.10.070
Wang H, Liang S, Wang M et al (2016) Potential serum biomarkers from a metabolomics study of autism. J Psychiatry Neurosci 41(1):27–37. https://doi.org/10.1503/jpn.140009
Niedzwiecki MM, Walker DI, Howell JC et al (2020) High-resolution metabolomic profiling of Alzheimer’s disease in plasma. Ann Clin Transl Neurol 7(1):36–45. https://doi.org/10.1002/acn3.50956
Dubuis S, Ortmayr K, Zampieri M (2018) A framework for large-scale metabolome drug profiling links coenzyme a metabolism to the toxicity of anti-cancer drug dichloroacetate. Commun Biol 1(1):1–11. https://doi.org/10.1038/s42003-018-0111-x
Zampieri M, Szappanos B, Buchieri MV et al (2018) High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds. Sci Transl Med 10(429). https://doi.org/10.1126/scitranslmed.aal3973
Steuer AE, Brockbals L, Kraemer T (2019, May) Metabolomic strategies in biomarker research-new approach for indirect identification of drug consumption and sample manipulation in clinical and forensic toxicology. Front Chem 7. https://doi.org/10.3389/fchem.2019.00319
Díaz C, Pérez Del Palacio J, Valero-Guillén PL et al (2019) Comparative metabolomics between mycobacterium tuberculosis and the MTBVAC vaccine candidate. ACS Infect Dis 5(8):1317–1326. https://doi.org/10.1021/acsinfecdis.9b00008
His M, Viallon V, Dossus L et al (2019) Prospective analysis of circulating metabolites and breast cancer in EPIC. BMC Med 17(1). https://doi.org/10.1186/s12916-019-1408-4
Isa F, Collins S, Lee MH et al (2018) Mass spectrometric identification of urinary biomarkers of pulmonary tuberculosis. EBioMedicine 31:157–165. https://doi.org/10.1016/j.ebiom.2018.04.014
Wurtz P, Havulinna AS, Soininen P et al (2015) Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation 131(9):774–785. https://doi.org/10.1161/CIRCULATIONAHA.114.013116
Pinu FR, Goldansaz SA, Jaine J (2019) Translational metabolomics: current challenges and future opportunities. Meta 9(6). https://doi.org/10.3390/metabo9060108
Walker DI, Valvi D, Rothman N, Lan Q, Miller GW, Jones DP (2019) The metabolome: a key measure for exposome research in epidemiology. Curr Epidemiol Rep 6:93–103. https://doi.org/10.1007/s40471-019-00187-4
Gangemi S, Gofita E, Costa C et al (2016) Occupational and environmental exposure to pesticides and cytokine pathways in chronic diseases (review). Int J Mol Med 38(4):1012–1020. https://doi.org/10.3892/ijmm.2016.2728
Beger RD, Dunn W, Schmidt MA, et al. (2016) Metabolomics enables precision medicine: “A White Paper, Community Perspective.” Metabolomics 12(10). https://doi.org/10.1007/s11306-016-1094-6
Castelli FA, Rosati G, Moguet C et al (2021) Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests. Anal Bioanal Chem. https://doi.org/10.1007/s00216-021-03586-z
Chevre R, Silvestre-Roig C, Soehnlein O (2018) Nutritional modulation of innate immunity: the fat–bile–gut connection. Trends Endocrinol Metab 29(10):686–698. https://doi.org/10.1016/j.tem.2018.08.002
Romick-Rosendale LE, Haslam DB, Lane A et al (2018) Antibiotic exposure and reduced short chain fatty acid production after hematopoietic stem cell transplant. Biol Blood Marrow Transplant 24(12):2418–2424. https://doi.org/10.1016/j.bbmt.2018.07.030
Sen P, Lamichhane S, Mathema VB et al (2021) Deep learning meets metabolomics: a methodological perspective. Brief Bioinform 22(2):1531–1542. https://doi.org/10.1093/bib/bbaa204
Liebal UW, Phan ANT, Sudhakar M, Raman K, Blank LM (2020) Machine learning applications for mass spectrometry-based metabolomics. Meta 10(6):1–23. https://doi.org/10.3390/metabo10060243
Pomyen Y, Wanichthanarak K, Poungsombat P, Fahrmann J, Grapov D, Khoomrung S (2020) Deep metabolome: applications of deep learning in metabolomics. Comput Struct Biotechnol J 18:2818–2825. https://doi.org/10.1016/j.csbj.2020.09.033
Díaz-Beltrán L, González-Olmedo C, Luque-Caro N et al (2021) Human plasma metabolomics for biomarker discovery: targeting the molecular subtypes in breast cancer. Cancers (Basel) 13(1):1–18. https://doi.org/10.3390/cancers13010147
Quinn KD, Nguyen NQT, Wach MM, Wood TD (2012) Tandem mass spectrometry of Bilin tetrapyrroles by electrospray ionization and collision-induced dissociation. Rapid Commun Mass Spectrom 26(16):1767–1775. https://doi.org/10.1002/rcm.6287
Giesbertz P, Ecker J, Haag A, Spanier B, Daniel H (2015) An LC-MS/MS method to quantify acylcarnitine species including isomeric and odd-numbered forms in plasma and tissues. J Lipid Res 56(10):2029–2039. https://doi.org/10.1194/jlr.D061721
Hsu FF, Turk J (2003) Electrospray ionization/tandem quadrupole mass spectrometric studies on phosphatidylcholines: the fragmentation processes. J Am Soc Mass Spectrom 14(4):352–363. https://doi.org/10.1016/S1044-0305(03)00064-3
Pulfer M, Murphy RC (2003) Electrospray mass spectrometry of phospholipids. Mass Spectrom Rev 22(5):332–364. https://doi.org/10.1002/mas.10061
Hsu FF, Turk J, Thukkani AK, Messner MC, Wildsmith KR, Ford DA (2003) Characterization of alkylacyl, alk-1-enylacyl and lyso subclasses of glycerophosphocholine by tandem quadrupole mass spectrometry with electrospray ionization. J Mass Spectrom 38(7):752–763. https://doi.org/10.1002/jms.491
Brouwers JFHM, Vernooij EAAM, Tielens AGM, Van Golde LMG (1999) Rapid separation and identification of phosphatidylethanolamine molecular species. J Lipid Res 40(1):164–169. https://doi.org/10.1016/s0022-2275(20)33352-6
Kerwin JL, Tuininga AR, Ericsson LH (1994) Identification of molecular species of glycerophospholipids and sphingomyelin using electrospray mass spectrometry. J Lipid Res 35(6):1102–1114. https://doi.org/10.1016/s0022-2275(20)40106-3
Pi J, Wu X, Feng Y (2016) Fragmentation patterns of five types of phospholipids by ultra-high-performance liquid chromatography electrospray ionization quadrupole time-of-flight tandem mass spectrometry. Anal Methods 8(6):1319–1332. https://doi.org/10.1039/C5AY00776C
Acknowledgments
We would like to thank Fundación MEDINA for funding and Dr. José Pérez del Palacio for technical support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Díaz, C., González-Olmedo, C. (2023). Untargeted Metabolomics by Liquid Chromatography–Mass Spectrometry in Biomedical Research. In: González-Domínguez, R. (eds) Mass Spectrometry for Metabolomics. Methods in Molecular Biology, vol 2571. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2699-3_6
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2699-3_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2698-6
Online ISBN: 978-1-0716-2699-3
eBook Packages: Springer Protocols